關鍵數據
0.440今開
--最高
0.00成交量
虧損本益比TTM
虧損本益比動
--股利TTM
--換手率
0.420昨收
--最低
0.00成交額
虧損本益比靜
2.90市淨率
0.00%股息率 TTM
-310.39%ROA
4.00052週最高
--量比
-19.45M淨利潤
56.35M總股本
-0.5587每股盈餘TTM
-0.86Beta
-495.61%ROE
0.39052週最低
--振幅
--毛利率
23.72M總市值
-1.71回報/風險
9.43%風險率

即將為您帶來更多新聞,敬請期待。 。 。
分析師評級
買入評級
3.167目標均價
+645.10%漲幅空間
Heartbeam Inc 最新財報電話會記錄
HeartBeam (BEAT) 2026 年第二季財報電話會議:FDA 遞件,降低現金消耗與商業化上市
HeartBeam 的 2026 年第二季財報電話會議內容涵蓋 500 萬美元的淨虧損、較低的現金消耗、FDA 的相關進展,以及在美國四個市場的早期商業化推廣。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Heartbeam Inc 簡介
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
行業醫療設備與耗材
公司代碼BEAT
員工數量21
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Strome Mezzanine Fund, L.P. | 5.87% |
|---|
| Schwartzberg (Andrew) | 3.54% |
|---|
| Vanguard Capital Management, LLC | 2.23% |
|---|
| Public Ventures LLC | 1.99% |
|---|
| 股東類型 | 佔比 |
|---|
| Individual Investor | 8.06% |
|---|
| Corporation | 7.86% |
|---|
| Investment Advisor | 7.40% |
|---|
| Investment Advisor/Hedge Fund | 1.15% |
|---|
常見問題
Heartbeam Inc(BEAT)的當前股價是多少?
Heartbeam Inc(BEAT)的當前股價是 0.42。
Heartbeam Inc股票的52週最高點是多少?
Heartbeam Inc股票的52週最高點是4.00。
Heartbeam Inc股票的52週最低點是多少?
Heartbeam Inc股票的52週最低點是0.39。
現在Heartbeam Inc(BEAT)的股票是買入、持有還是賣出?
根據分析師評級,Heartbeam Inc(BEAT)的總體評級為買入,目標價格為3.17。
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是多少
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是-0.56。